NSF experts include former regulators who perform audits and mock inspections across the product lifecycle. The team also audits suppliers and service providers to the pharmaceutical industry.
NSF's team provides the following audits:
Pharmaceutical quality systems audits
NSF assesses the quality systems that govern pharmaceutical and biotech operations, including GMP compliance, documentation practises, CAPA, deviation management, supplier oversight and inspection readiness. In some markets, these assessments may be referred to as PQS or QMS audits.
Supplier and contractor audits for pharma and biotech supply chains
NSF helps pharma and biotech teams evaluate suppliers, contractors and external manufacturing partners before quality issues become regulatory or operational risks. The team's audit experts can support supplier qualification, contractor oversight, requalification audits, quality agreement reviews and follow-up assessments across regulated supply chains.
These audits can help teams understand whether suppliers and contractors are operating in alignment with GMP expectations, internal quality standards and applicable regulatory requirements.
GxP audits across GLP, GCP, GMP, PV and GDP requirements
NSF provides audit and mock-inspection support across key GxP areas, including GLP, GCP, GMP, pharmacovigilance and GDP. NSF's life sciences audit experts can help assess whether procedures, documentation, training, data integrity controls and operational practises are aligned with applicable regulatory expectations.
Whether the need is site readiness, supplier oversight, documentation review or post-finding follow-up, NSF experts can help identify gaps and support practical next steps for remediation.
NSF supplier and contractor audits can support:
- Supplier qualification and requalification.
- Contractor and CMO oversight.
- Quality agreement review.
- GMP documentation and process review.
- CAPA and deviation follow-up.
- Risk-based supplier management.
